Beyond Topoisomerase Inhibition: Antitumor 1,4‐Naphthoquinones as Potential Inhibitors of Human Monoamine Oxidase
Authors:
- Eduardo Coelho-CerqueiraECEduardo Coelho-Cerqueira
- Paulo A NetzPNPaulo A Netz
- Vanessa P Do CantoVCVanessa P Do Canto
- Cristian FollmerCFCristian Follmer
- 18 March 2014
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 83 (4) , 401-410
Abstract
Monoamine oxidase (MAO) action has been involved in the regulation of neurotransmitters levels, cell signaling, cellular growth, and differentiation as well as in the balance of the intracellular polyamine levels. Although so far obscure,MAOinhibitors are believed to have some effect on tumors progression. 1,4‐naphthoquinone (1,4‐NQ) has been pointed out as a potential pharmacophore for inhibition of bothMAOandDNAtopoisomerase activities, this latter associated with antitumor activity. Herein, we demonstrated that certain antitumor 1,4‐NQs, including spermidine‐1,4‐NQ, lapachol, andnor‐lapachol display inhibitory activity on humanMAO‐A andMAO‐B. Kinetic studies indicated that these compounds are reversible and competitiveMAOinhibitors, being the enzyme selectivity greatly affected by substitutions on 1,4‐NQring. Molecular docking studies suggested that the most potentMAOinhibitors are capable to bind to theMAOactive site in close proximity of flavin moiety. Furthermore, ability to inhibit bothMAO‐A andMAO‐B can be potentialized by the formation of hydrogen bonds between these compounds andFADand/or the residues in the active site. Although spermidine‐1,4‐NQs exhibit antitumor action primarily by inhibiting topoisomerase viaDNAintercalation, our findings suggest that their effect onMAOactivity should be taken into account when their application in cancer therapy is considered.Keywords
This publication has 34 references indexed in Scilit:
- Molecular insights into human monoamine oxidase (MAO) inhibition by 1,4-naphthoquinone: Evidences for menadione (vitamin K3) acting as a competitive and reversible inhibitor of MAOBioorganic & Medicinal Chemistry, 2011
- Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cellsBMC Medical Genomics, 2009
- Monoamine oxidase B activity is increased in human gliomasNeurochemistry International, 2008
- Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illnessBritish Journal of Pharmacology, 2006
- Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cellsNeurochemistry International, 2005
- Biogenic amines and apoptosis: Minireview articleAmino Acids, 2004
- Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Monoamine oxidase: radiotracer development and human studiesMethods, 2002
- Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco LeavesChemical Research in Toxicology, 1999
- Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proceedings of the National Academy of Sciences, 1985